3 days Ago By Defense World Staff
HC Wainwright restated their buy rating on shares of Purple Biotech ( NASDAQ:PPBT – Free Report ) in a report released on Friday morning, Benzinga reports. HC Wainwright currently has a $33.00 target price on the stock.
Purple Biotech Stock Up 1.8 % Purple Biotech stock opened at $2.55 on Friday.
The business has a 50 day moving average price of $7.45. Purple Biotech has a 52 week low of $2.
41 and a 52 week high of $23.20. The firm has a market cap of $3.
39 million, a price-to-earnings ratio of -0.29 and a beta of 1.11.
Purple Biotech ( NASDAQ:PPBT – Get Free Report ) last posted its quarterly earnings data on Friday, August 16th. The company reported ($1.60) EPS for the quarter, topping analysts’ consensus estimates of ($2.
60) by $1.00. Equities analysts expect that Purple Biotech will post -6.
42 earnings per share for the current year. About Purple Biotech Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States.
Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and IM1240, a multi-valent antibody designed to activate anti-tumoral immune response against 5T4-positive tumors, which is in preclinical stage. Read More Five stocks we like better than Purple Biotech What Are Dividends? Buy the Best Dividend Stocks Is Monolithic Power Systems a Screaming Buy After Near 40% Drop? Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index Applied Materials Market Capitulates: Now is the Time to Buy ESG Stocks, What Investors Should Know 3 Ultra-High Dividend Yield Stocks for the New Year Receive News & Ratings for Purple Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Purple Biotech and related companies with MarketBeat.com's FREE daily email newsletter .
.
